The initial public offering comes just five months after the company raised $80 million to push forward it?s cancer drug research in October
News Ticker
- [ August 2, 2021 ] Rethinking Remdesivir News
- [ August 2, 2021 ] SVP, Business Development – Propeller Health – ResMed – San Diego, CA San Diego Biotech Jobs
- [ August 2, 2021 ] Assistant/Associate Director, Quality Assurance – Computer System Validation and Administration – Ionis Pharmaceuticals, Inc. – Carlsbad, CA San Diego Biotech Jobs
- [ August 2, 2021 ] Sorrento Receives FDA Authorization to Start Phase 1 Clinical Trial of Proprietary, “Off-the-Shelf”, Allogeneic anti-CD38 DAR-T (Dimeric Antigen Receptor-T) Cell Therapy to Treat Relapsed or Refractory Multiple Myeloma News
- [ August 2, 2021 ] Avidity Biosciences, Inc. Announces Proposed Public Offering of Common Stock News
Copyright © 2021 Biotech Networks, LLC
